在出血和血栓形成中的V因子变异
Adarsh K Mohapatra1, Alice M Todaro1, Elisabetta Castoldi1
1Department of Biochemistry, CARIM, Maastricht University, Maastricht, the Netherlands.
Research and practice in thrombosis and haemostasis
|February 26, 2024
概括
因素V (FV) 变异影响静血平衡,影响出血和血栓形成的风险. 在F5基因的突变可以改变FV.
科学领域:
- 血液学 血液学 血液学
- 分子生物学分子生物学
- 遗传学 是一个遗传学.
背景情况:
- 血液凝固是一系列复杂的过程,涉及酶反应.
- 因素V (FV) 是至关重要的,作为一种促凝剂和抗凝剂的辅因子.
- 静脉功能失衡与出血障碍和静脉血栓症有关.
研究的目的:
- 审查V因子的促凝和抗凝作用.
- 探索F5基因突变如何影响静血平衡.
- 讨论与FV功能障碍相关的病理状况.
主要方法:
- 关于因子V的科学文献的综述.
- 分析F5基因突变及其功能后果.
- 讨论病理状况,包括FV缺乏,APC耐药性和FV短.
主要成果:
- 维因子在凝血中表现出双重作用,对血栓生成和凝血调节至关重要.
- F5基因突变会破坏促凝剂/抗凝剂平衡,导致出血或血栓形成.
- FV缺陷,APC耐药性和FV短过度表达是关键的病理状态.
结论:
- 维因子是血液静止的中央调节剂.
- 了解F5基因变异对于诊断和管理出血和血栓性疾病至关重要.
- 像FV-short这样的FV异型的新兴角色需要进一步的研究.
更多相关视频
相关概念视频
Anticoagulant Drugs: Low-Molecular-Weight Heparins
697
Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
697
Disorders of Hemostasis
906
Hemostasis, the process that stops bleeding after a blood vessel injury, is crucial for maintaining the integrity of the circulatory system. However, disorders of hemostasis can disrupt this delicate balance, leading to either excessive clotting or bleeding. These disorders can be broadly classified into thromboembolic disorders and bleeding disorders.
Thromboembolic Disorders
Two factors primarily cause thromboembolic conditions.
Thromboembolic Disorders
Two factors primarily cause thromboembolic conditions.
906
Extrinsic and Intrinsic Pathways of Hemostasis
7.6K
Blood clotting or coagulation involves extrinsic and intrinsic pathways, which ultimately merge into the common pathway, forming a fibrin clot.
The Extrinsic Pathway
The extrinsic pathway of coagulation is typically initiated by tissue damage that exposes blood to tissue factor (TF), a protein released by the damaged tissue cells outside the blood vessels—this interaction with TF triggers biochemical reactions involving specific clotting factors. The key player here is Factor VII, which...
The Extrinsic Pathway
The extrinsic pathway of coagulation is typically initiated by tissue damage that exposes blood to tissue factor (TF), a protein released by the damaged tissue cells outside the blood vessels—this interaction with TF triggers biochemical reactions involving specific clotting factors. The key player here is Factor VII, which...
7.6K
Coagulation
6.6K
The coagulation phase is a critical part of the body's process to prevent blood loss following injury to blood vessels. It involves chemical reactions that form a clot to seal the injured area. The clotting process begins shortly after injury, within 15-20 seconds for severe damage and 1-2 minutes for minor injuries.
During the coagulation phase, clotting factors, or procoagulants, play a vital role in initiating and progressing the coagulation cascade. This cascade is a series of reactions...
During the coagulation phase, clotting factors, or procoagulants, play a vital role in initiating and progressing the coagulation cascade. This cascade is a series of reactions...
6.6K
Clot Retraction and Fibrinolysis
5.9K
After a fibrin clot is formed, the next step is clot retraction, a vital process facilitated by platelet contractile proteins, such as actin and myosin. These proteins pull the fibrin strands closer together and condense the clot. This action reduces the size of the clot, creating a smaller, denser structure that effectively seals off the damaged vessel. Clot retraction consolidates the clot and helps with wound healing by bringing the edges of the damaged blood vessel closer together.
5.9K
Introduction to Hemostasis
7.7K
Hemostasis is a complex physiological process that prevents excessive bleeding when a blood vessel is injured. It's crucial for maintaining the integrity of the circulatory system, as it ensures that our blood remains fluid while still within the vascular network and yet clots to prevent blood loss upon vessel injury.
The three phases of hemostasis involve many clotting factors present in plasma and several substances released by platelets and injured tissue cells. It is a fast, localized,...
The three phases of hemostasis involve many clotting factors present in plasma and several substances released by platelets and injured tissue cells. It is a fast, localized,...
7.7K


